CDEK
← All organizations

MyoKardia, Inc.

For profitWebsite ↗

Also known as: MyoKardia, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Dec 1, 2014

Last known activity

Mar 30, 2021

Acquired by Bristol-Myers Squibb on Oct 5, 2020

Timeline

2010s

  1. Jun 1, 2012

    MyoKardia, Inc.— Founded

2020s

  1. Oct 5, 2020

    Bristol-Myers Squibb— Acquired By

Drugs by trial phase (2 distinct, 13 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (18)

Details

Founded
San Francisco, CA, US Jun 1, 2012
Last known activity
Mar 30, 2021